Vein of Marshall Ethanol Infusion for Recurrent Atrial Fibrillation Patients Presenting for Redo Ablation: A Systematic Review and Meta‐Analysis
- 15 May 2026
- journal article
- review article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (6) , 1340-1352
Abstract
Randomized trials of ethanol infusion into the vein of Marshall (EIVOM) have shown efficacy in preventing atrial fibrillation (AF) recurrence in patients presenting for de novo ablation. The utility of EIVOM in AF patients who present for redo ablation is unclear. This meta‐analysis was reported according to the Preferred Reporting Items for Systematic Review and Meta‐Analyses guidelines. Medline, Scopus, and Cochrane Central Register of Controlled Trials were systematically searched to identify relevant studies. Risk of bias was assessed using the Modified Newcastle‐Ottawa scale. Eligible studies reported outcomes in AF patients with previous ablation who underwent redo catheter ablation (CA) alone vs. combined redo CA and EIVOM. Five observational studies comprising 568 patients were included. When comparing combined redo CA and EIVOM vs. redo CA alone, pooled results showed no difference in freedom from arrhythmia (FFA) in all patients (risk ratio [RR] 1.13; 95% confidence interval [CI] 0.96–1.33), FFA in persistent AF patients only (RR 1.08; 95% CI 0.90–1.29), total procedure time (mean difference −0.59; 95% CI −41.04–39.85), or major periprocedural complications (RR 0.81; 95% CI 0.06–11.64). Patients with AF recurrence after ablation represent a difficult‐to‐treat population. Salvage therapy with combined CA and EIVOM did not improve arrhythmic outcomes compared to CA alone in AF patients who presented for redo ablation.Keywords
This publication has 43 references indexed in Scilit:
- Posterior wall isolation with pulsed field ablation or radiofrequency ablation with vein of Marshall ethanol ablation for repeat catheter ablation of recurrent atrial fibrillationJournal of Interventional Cardiac Electrophysiology, 2025
- Ethanol infusion into the vein of Marshall reduced atrial tachyarrhythmia recurrence during catheter ablation: A systematic review and meta-analysisHeart Rhythm O2, 2024
- Vein of Marshall ethanol infusion for recurrent atrial fibrillation in patients with durably isolated pulmonary veinsJournal of Interventional Cardiac Electrophysiology, 2024
- Efficacy and feasibility of vein of Marshall ethanol infusion during persistent atrial fibrillation ablation: A systematic review and meta‐analysisClinical Cardiology, 2023
- Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial FibrillationJAMA, 2020
- Vein of Marshall ethanol infusion for persistent atrial fibrillation: VENUS and MARS clinical trial designAmerican Heart Journal, 2019
- Ethanol infusion in the vein of Marshall facilitates mitral isthmus ablationHeart Rhythm, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Outcomes of long-standing persistent atrial fibrillation ablation: A systematic reviewHeart Rhythm, 2010
- Electrophysiological characteristics of the Marshall bundle in humansHeart Rhythm, 2010